Catalent, Inc.
Catalent, Inc. is a global provider of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. The company's strategic ambition is to power the innovation and growth of the life science industry by becoming the leading development and commercial partner in reliable supply, conventional and advanced technologies, first-to-scale innovation, and therapeutic modalities. Catalent has a diverse range of offerings and serves a broad customer base, including 87 of the top 100 branded drug and consumer health marketers and 82 of the top 100 biologics marketers. The company's business segments include biologics, branded drugs, generic prescription drugs, over-the-counter drugs, and consumer health and other. Catalent's website is catalent.com, and its ticker symbol is CTLT on the New York Stock Exchange.